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Although the isoflavone genistein has well-established health-beneficial effects, it is not a 24 
major component of Western diet, since soy consumption, the main dietary source of 25 
genistein, is low in these populations. Genistein compounds were studied in twelve 26 
commercial sour cherry (Prunus cerasus L.) cultivars grown in Hungary. High performance 27 
liquid chromatography coupled to quadrupole/time-of-flight mass spectrometry, equipped 28 
with electrospray ion source (HPLC-ESI-qTOFMS) was used for screening and confirmatory 29 
analyses. Genistin and genistein were found in some Hungarian native sour cherry cultivars 30 
including ‘Pipacs1’, ‘Kántorjánosi’, ‘Debreceni bőtermő’ and ‘Éva’. Genistein content in 31 
fruits of the latter three cultivars  ranged between 0.4 to 0.6 mg, while in ‘Pipacs1’ a total of 32 
4.4 mg genistein compounds (expressed as aglycone equivalents per 100 g of fresh fruit) was 33 
determined. These cultivars may play an important role as complementary genistein sources 34 
in the Western diet. Especially ‘Pipacs 1’, may be best utilized in functional food products.  35 
 36 




1. Introduction 39 
Polyphenols are plant secondary metabolites, which have drawn interest in food science, since 40 
an impressive list of health benefits was associated with these compounds when they 41 
consumed in various forms of polyphenol-rich plant foods (Crozier, Jaganath, & Clifford, 42 
2009; Del Rio, Rodriguez-Mateos, Spencer, Tognolini, Borges, & Crozier, 2013). Genistein – 43 
a polyphenol compound belonging to the subclass of isoflavones – also showed various 44 
health-beneficial effects in numerous experiments due to its multiple mechanisms of action. 45 
For instance, genistein can improve lipid profile and lower blood pressure and hence exert 46 
cardiovascular protection (Schwab, Stein, Scheler, & Theuring, 2012). Genistein was also 47 
proved to be a promising therapeutic agent at least for ameliorating diabetes and obesity states 48 
(Behloul & Wu, 2013). However, most studies on the health beneficial effects of genistein are 49 
focusing on its cancer preventive properties. It has been shown that genistein can induce 50 
apoptosis in haematological tumour cells through multiple mechanisms, while protecting 51 
normal cells from toxicity. Genistein is also a potent growth inhibitor of breast, prostate, 52 
pancreatic, melanoma, and kidney cancer cells in vitro (Li, Frame, Hirsch, & Cobos, 2010). In 53 
a recent study, daidzein and genistein were effectively induced apoptosis in HT-29 colon 54 
cancer cells (G. N. Kim, Song, Kim, Choi, & Jang, 2012).  55 
In substantial amounts, genistein has been found almost exclusively in leguminous plants so 56 
far with the highest concentration occurring in soybean (Glycine max). Therefore, soybean is 57 
considered as the main dietary source of genistein (Liggins, Bluck, Runswick, Atkinson, 58 
Coward, & Bingham, 2000a, 2000b). Concentrations of genistein in soybean are inherently 59 
heterogeneous depending on type, climate, crop year, and location of the cultivation plot 60 
(Chan, Murphy, Ho, Kreiger, Darlington, So, et al., 2009). According to a comprehensive 61 
database for the isoflavone content of selected foods, published by the US Department of 62 
Agriculture, genistein varied in the range of 5.6-276 mg/100 g in raw mature soybeans 63 
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(Bhagwat, Haytowitz, & Holden, 2008). Soy is still a staple food in Asia, but it is a relative 64 
newcomer at the dinner table in other parts of the world, which means that human exposure to 65 
genistein varies widely because of cultural differences in diet (Li, Frame, Hirsch, & Cobos, 66 
2010). This might explain the conclusion achieved in a number of human studies i.e. risk of 67 
the cancers where genistein proved to have preventive actions is lower in Japan and China 68 
than in the US and Europe (Kurahashi, Iwasaki, Inoue, Sasazuki, & Tsugane, 2008; Lampe, 69 
Nishino, Ray, Wu, Li, Lin, et al., 2007; Yang, Shu, Chow, Zhang, Li, Ji, et al., 2012)  70 
In contrast to its well-established health beneficial effects, the genistein isoflavone  is not a 71 
major component of the Western diet, since soy food intake in these populations is typically 72 
low (Crozier, Del Rio, & Clifford, 2010; Crozier, Jaganath, & Clifford, 2009; Lampe, et al., 73 
2007). However, in addition to soybean, genistein is also present in small quantities in a 74 
number of edible plants. According to the studies of Liggins et al. only legumes contained 0.2 75 
- 0.6 mg genistein and daidzein per 100 g of wet weight of food among foods commonly 76 
eaten in Europe (Liggins, Bluck, Runswick, Atkinson, Coward, & Bingham, 2000b). With 77 
respect to fruits, they found that currants and raisins were the richest sources of the 78 
isoflavones, containing around 0.2 mg of the genistein and daidzein combined per 100 g of 79 
wet weight of food (Liggins, Bluck, Runswick, Atkinson, Coward, & Bingham, 2000a). In 80 
this context peanut should be also mentioned containing genistein and daidzein around 0.03 81 
mg/100 g (Chukwumah, Walker, Vogler, & Verghese, 2012). In a recent study, it was shown 82 
that genistein occurred in groundnut among others in the form of genistein-7-O-83 
genitiobioside, a glycoconjugate that has not been detected before (Nara, Nihei, Ogasawara, 84 
Koga, & Kato, 2011). Considering the genistein concentrations typical in plant foods, clearly 85 
the inclusion of even a small portion of a soy product in the diet will expose consumers to 86 
very significant concentrations of daidzein and genistein. Nevertheless, fruits, nuts, and 87 
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vegetables contain a broad range of concentrations of these compounds and will contribute to 88 
the daily dietary intake (Liggins, Bluck, Runswick, Atkinson, Coward, & Bingham, 2000a).  89 
Sour or tart cherries (Prunus cerasus L.) are commercially important and consumed in a 90 
variety of ways, including fresh, frozen, canned, brined or dried fruits or as juice. 91 
Anthocyanins and other flavonoids, as well as melatonin, in various cultivars were analysed, 92 
and it has been known that sour cherries contain substantial amounts of anthocyanins and 93 
phenolic acids (Ficzek, Vegvari, Sandor, Steger-Mate, Kallay, Szugyi, et al., 2011; 94 
Kirakosyan, Seymour, Llanes, Kaufman, & Bolling, 2009). So far, studies focusing on the 95 
benefitial health-effects of sour cherry consumption are scarce; however, a few interesting 96 
papers are available reporting on the biological effects of sour cherry constituents present in 97 
fruit (Hevesi, Blázovics, Kállay, Végh, Stéger-Máté, Ficzek, et al., 2012; Khoo, Clausen, 98 
Pedersen, & Larsen, 2011; D. O. Kim, Heo, Kim, Yang, & Lee, 2005) and seed kernel (Bak, 99 
Lekli, Juhasz, Varga, Varga, Gesztelyi, et al., 2010). Data on the genistein content of sour 100 
cherries are very limited (Wang, Nair, Strasburg, Booren, & Gray, 1999). Its reason might be 101 
that most cultivars do not contain genistein in detectable amounts; however, natural variation 102 
among sour cherry cultivars might be considerable, as is known to occur in soya (Bhagwat, 103 
Haytowitz, & Holden, 2008; Chan, et al., 2009). 104 
In this study, twelve sour cherry (Prunus cerasus L.) genotypes (including commercial 105 
cultivars and cultivar candidates) grown in Hungary were screened for genistein compounds 106 
in a non-target manner. High performance liquid chromatography coupled to 107 
quadrupole/time-of-flight mass spectrometry, equipped with electrospray ion source (HPLC-108 
ESI-qTOFMS) was used for screening and confirmatory analyses of indicated genistein 109 
glycoconjugates. In addition, UV spectra of the indicated compounds were also provided for 110 





2. Materials and methods 114 
2.1 Plant material 115 
Twelve sour cherry (Prunus cerasus L.) genotypes were tested in the present study, most of 116 
which are of Carpathian Basin origin (Hungary or Serbia). Studied genotypes are listed in 117 
Table 2. All cultivars were cultivated at the same germplasm collection in the Research and 118 
Extension Centre for Fruit Growing (Újfehértó, Eastern Hungary, 47  N latitude, 21 E 119 
longitude and 122 m altitude). Fruits were harvested in June-July 2009 and 2010 at 120 
consumption maturity stage.  121 
 122 
2.2. Chemicals and standards 123 
Acetonitrile and methanol (Prolabo HiPerSolv) used were super gradient grade. Formic acid 124 
(98% for mass spectrometry) was obtained from Fluka. Crystalline reference substances of 125 
genistein aglycone and genistein-7-O--D-glucoside (genistin) and daidzein were obtained 126 
from Extrasynthese (Genay, France). A Milli-Q ultrapure water system was used throughout 127 
the study to obtain high purity water. 128 
 129 
2.3. Sample preparation 130 
Sour cherry fruits were halved and pitted before lyophilisation. Lyophilized samples were 131 
pulverized and an amount of 200 mg was extracted for 40 min with 10 ml 60/39/1 132 
methanol/water/formic acid solution using an ultrasonic bath. Extracts were centrifuged and 4 133 
ml supernatant was evaporated approximately to 0.5-0.7 ml in a vacuum centrifuge. 134 
Afterwards 100 µl acetonitrile 10 l 1:1 diluted formic acid was added and the samples were 135 
reconstituted to 1 ml with water and were thoroughly vortexed. For the standard addition 136 
calibration, aqueous methanolic (80/20) standard solutions of genistein aglycone and genistin 137 
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were added to aliquots of the reconstituted samples. Daidzein aglycone was added to all 138 
samples as internal standard. Spiked aliquots were further diluted with water (1:10 or 1:20 139 
depending on the sample) for quantitative MS measurements. All samples were filtered 140 
through a 0.45-μm PTFE syringe filter before injecting to the HPLC. 141 
 142 
2.4 Chromatographic separation 143 
Chromatographic separation was carried out on a Phenomenex Kinetex C18, 4.6×150 mm, 2.6 144 
μm column using an Agilent 1200 series HPLC system. For the elution, 0.5% (v/v) formic 145 
acid in water (mobile phase A) and 0.5% (v/v) formic acid in acetonitrile (mobile phase B) 146 
were used as solvents at a flow rate of 500 μl/min. The gradient program started at 8% B, and 147 
after 5 min of isocratic run, solvent B was increased linearly and reached 45% at 35 min and 148 
then 100% at 40 min. Finally, 100% B was kept constant for 5 min.  149 
 150 
2.5 Screening of genistein compounds by HPLC-DAD-ESI-qTOFMS  151 
For qualitative (screening and confirmatory) analysis the HPLC system including a diode 152 
array detector (DAD) was coupled to an Agilent 6530 quadrupole – time-of-flight (q-TOF) 153 
hybrid mass spectrometer, equipped with a dual spray ESI source. Positive ion mode was used 154 
in all experiments. The q-TOFMS was used with the following operation parameters: 155 
capillary voltage, 4,000 V; nebulizer pressure, 40 psig; drying gas flow rate, 13 l/min; gas 156 
temperature, 350 °C. During these experiments, fragmentor voltage was triggered 157 
automatically between 160 V and 210 V. The lower value is representing mild conditions in 158 
order to minimize in-source fragmentation, while the higher one is to foster in-source 159 
fragmentation. Full-scan mass spectra in the range of m/z 50-1100 were recorded at 1.5 160 
spectra/s scanning speed at all times during the chromatographic run. The instrument 161 
performed the internal mass calibration automatically, using an automated calibrant delivery 162 
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system, which introduces the flow from the outlet of the chromatograph together with a low 163 
flow (approximately 10 μl/min) of a calibrating solution. The solution contains the internal 164 
reference masses of HP-921 [hexakis-(1H,1H,3H-tetrafluoro-pentoxy)-phosphazene] and 165 
purine. Protonated molecules of purine ([C5H4N4]
+
 at m/z 121.050873) and HP-0921 166 
([C18H19O6N3P3F24]
+
 at m/z 922.009798) were used as reference masses. The DAD was 167 
acquiring data in the range of 200-800 nm in 2 nm steps at 0.5 spectra/s acquisition speed. 168 
 169 
2.6 Quantitation of genistein compounds by HPLC-DAD-ESI-MS/MS 170 
Quantification of found genistein compounds was carried out using the HPLC system 171 
including the DAD coupled to an Applied Biosystems (Foster City, CA, USA) 3200 Q-Trap 172 
hybrid triple quadrupole/linear ion trap MS/MS instrument equipped with a Turbo-V ESI ion 173 
source that was used in the positive ion mode. Multiple reaction monitoring (MRM) scan 174 
mode was used for mass spectrometric quantification of genistein and genistin using the 175 
standard addition calibration technique. The tentatively identified other genistein-hexoside 176 
compound was quantified based on UV absorbance signal at 260 nm using the calibration 177 
curve obtained for genistin at the same wavelength.  178 
 179 
3. Results and discussion 180 
3.1. HPLC-DAD-ESI-TOFMS profiling of genistein glycoconjugates 181 
Sour cherry extracts were screened for flavonoid glycoconjugates using an HPLC-DAD-ESI-182 
qTOFMS coupled analytical system. Compounds separated by HPLC were passed through the 183 
on-line coupled diode array detector (DAD) and then entering the ESI-MS system. First, for 184 
general-purpose flavonoid screening the qTOFMS system was used in TOF mode and 185 
quadrupole (q) was set to ‘RF only’ mode meaning that practically no mass filtering takes 186 
place in the quadrupole. During this preliminary screening step, in-source fragmentation was 187 
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utilized in order to provide structural information on the compounds. This approach offers the 188 
advantage that on the contrary to real tandem MS experiments, where precursor ion is 189 
selected and then subjected to fragmentation; here fragmentation information is obtained 190 
simultaneously on unlimited numbers of compounds without requiring any preliminary 191 
selection and isolation of the suspected ions.  192 
It is typical to flavonoid-O-glycosides that MS fragmentation primarily gives rise to product 193 
ions, which are formed by the cleavage of interglycosidic linkage or the linkage between the 194 
glycan part and the aglycone. Among the formed diagnostic ions, the aglycone fragment 195 
(often referred to as Y0 fragment) can be used to indicate the presence of a certain type of 196 
flavonoid, since the aglycone fragment will generally be formed from O-glycoside derivatives 197 
of the given aglycone (Abrankó, Garcia-Reyes, & Molina-Diaz, 2012). Results of the 198 
performed preliminary general-purpose flavonoid screening indicated that besides the well-199 
known flavonoid constituents of sour cherry (e.g. glycoconjugates of anthocyanidins such as 200 
cyanidin, and flavonols including quercetin and kaempferol) some analyzed samples seem to 201 
contain genistein compounds. This rather uncommon observation was further investigated. 202 
In Fig. 1, results obtained in ‘Pipacs1’ cultivar is shown. In Fig. 1A, the UV signal recorded at 203 
260 nm is plotted, which wavelength is the typical absorption maximum of genistein 204 
compounds (see Fig. 4). In Fig. 1B, the extracted ion chromatogram (EIC) of m/z 271.0601 is 205 
given, which is corresponding to [C15H11O5]
+
, representing the protonated genistein aglycone 206 
fragment (Y0
+
). (Throughout all TOFMS experiments, a 5 mDa mass window was used to 207 
extract m/z values of interest.) The appropriate retention time matching between UV and MS 208 
signals was obtained in five cases regarding the observed peaks, namely for peaks eluting at 209 
18.33, 21.03, 21.60, 22.73, and 31.33 min. Out of these five compounds, the last eluting one 210 
at 31.33 min was confirmed with reference standard as genistein aglycone. The remaining 211 
four compounds are supposed to be genistein glycoconjugates and the ion signals observed in 212 
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Fig. 1B are corresponding to the aglycone fragments (Y0
+
) cleaved from the original 213 
glycoconjugates during in-source fragmentation. 214 
In order to reveal the sugar (glycan) part of these supposed genistein glycoconjugates, a series 215 
of m/z values, which represent theoretical combinations of genistein aglycone and typical 216 
glycan part constituents, were extracted automatically using a home-made exact mass 217 
database. The glycan residue most often consists of building blocks of various hexoses such 218 
as glucose or galactose. Deoxyhexose (e.g. rhamnose) and pentose units such as xylose and 219 
arabinose are also common. Disaccharides are also often found in association with flavonoids, 220 
the most common ones are rutinose (rhamnosyl-(1→6)-glucose) and neohesperidose 221 
(rhamnosyl-(1→2)-glucose), and occasionally, tri- or even tetrasaccharides are encountered 222 
(Abad-García, Berrueta, Garmón-Lobato, Gallo, & Vicente, 2009).  223 
In Fig. 1C, EIC of m/z 433.1129 is given, representing a diagnostic ion for protonated 224 
genistein-hexoside (Gen-H). In three cases, namely for compounds at 18.33, 21.03, 22.73 225 
min, nice peaks were observed for Gen-H. In Fig. 1D, the EIC of the sodiated Gen-H (m/z 226 
455.0954) is shown. This diagnostic ion helped decide whether the supposed Gen-H peaks in 227 
Fig. 1C are only fragment ions of more complex genistein glycoconjugates or Gen-H is the 228 
sought intact compound. Since sodium adduct of a fragment will not be formed, once the 229 
sodiated ion occurs together with the protonated ion, there is no need to search more complex 230 
glycoconjugates. The appearance of sodium adduct is “capping” the molecule, and thus sets 231 
the endpoint of this bottom-up exploratory protocol (Abrankó, Garcia-Reyes, & Molina-Diaz, 232 
2012). The sodium adduct of Gen-H (Gen-H-Na) was not observed in case of the compound 233 
at 18.33 min indicating that this compound is a more complex glycolconjugate and only the 234 
formed Gen-H fragment of the intact compound produced the ion signal in Fig. 1C. Sodium 235 
caps of compounds at 21.03 and 22.73 min were found, which provide evidence that these 236 
compounds can be both tentatively identified as genistein-hexosides. The compound eluting at 237 
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21.03 min was confirmed with reference standard as genistein-7-O--D-glucoside also 238 
referred to as genistin. The sodium adduct of Gen-H (Gen-H-Na) also appeared for compound 239 
at 21.60 min; however, the [M+H]
+
 ion of Gen-H (m/z 433.1129) was not observed at this 240 
retention time. The missing Gen-H ion weakens the assumption that this compound also can 241 
be a genistein-hexoside, nonetheless UV signal at 260 nm and the available accurate mass 242 
spectral data for genistein aglycone fragment along with Gen-H-Na (see Fig. 1A, B and D) 243 
coherently support this assumption. 244 
In Fig. 1E and 1F, EICs of m/z 595.1658 and 617.1483 are shown; representing diagnostic 245 
ions for protonated genistein-dihexoside (Gen-H-H) and its sodium adduct (Gen-H-H-Na), 246 
respectively. As in case of the compound at 18.33 min both Gen-H-H and the sodium adduct 247 
appears, supporting that this compound can be tentatively identified as genistein-dihexoside. 248 
Diagnostic ions found for each compound along with the errors of MS identification of the 249 
ions of interest are summarized in Table 1. 250 
 251 
3.2 Additional confirmatory tandem MS and UV data relating to the detected genistein 252 
compounds. 253 
In addition to presented TOFMS results, further accurate mass tandem MS (qTOFMS) 254 
experiments along with UV spectrum acquisitions were carried out in order to provide 255 
additional confirmatory data strengthening the findings of profiling. Precursor ions 256 
corresponding to protonated Gen-H-H ([C27H31O15]
+
,  m/z 595.1658) in the case of compound 257 
eluting at 18.33 min and Gen-H ([C21H21O10]
+
, m/z 433.1129) for compounds at 21.03, 21.60 258 
and 22.73 min were selected respectively for targeted qTOF tandem MS experiments. In the 259 
mass spectra given in Fig. 2, [C15H11O5]
+
 fragment with the monoisotopic ion m/z 271.0601 260 
appears for all investigated glycoconjugates (with less than 1.5 mDa or 5 ppm error) as a 261 
pronounced peak, which represents the genistein aglycone fragment (Y0
+
) cleaved form the 262 
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original glycoconjugates. In the case of Gen-H-H at 18.33 min, the Gen-H fragment 263 
([C21H21O10]
+
, monoisotopic ion m/z 433.1129) also appears with 3.2 mDa or 7.4 ppm error 264 
(see Fig. 2A). It should be noted when qTOF tandem MS experiments were performed, the 265 
quadrupole (q) was working with a 4-Da-wide mass window to cover the isotopolouge cluster 266 
of the selected precursor compound. That is why in Fig. 2A an interfering ion peak with m/z 267 
594.2441 can be also seen closely next to the less abundant targeted one of m/z 595.1658. 268 
(The latter is indicated with a diamond symbol.) The fragment with the monoisotopic mass of 269 
m/z 271.0601 appearing commonly for all four glycoconjugates was assumed to be the 270 
genistein aglycone fragment (Y0
+
) cleaved from original compounds. However, this fragment 271 
with the supposed elemental composition of [C15H11O5]
+
 can also fit an isomeric compound of 272 
genistein. For instance the flavonoid apigenin has the same elemental composition and can 273 
also form glycoconjugates. It is noted that genistein aglycone (at 31.33 min) and genistin 274 
(genistein-7-O--D-glucoside) at 21.03 min were successfully confirmed with reference 275 
standards in ‘Pipacs1’ cultivar, as described before. It means that besides the accurate mass 276 
spectral data and UV signals at 260 nm, retention time matching with reference standards in 277 
case of these two compounds provided confirmatory data for the identification. With respect 278 
to the remaining three compounds at 18.33, 21.60 and 22.73 min, additional confirmatory data 279 
were collected in order to provide additional support to the hypothesis that the aglycone core 280 
of the compounds is genistein. In contrast with the previously described qTOFMS 281 
experiments, 210 V fragmentor voltage was used instead of 160 V, in order to encourage in-282 
source fragmentation of the glycoconjugates, similarly to ‘TOF-only’ profiling experiments. 283 
In this qTOFMS experiment however, m/z 271.0601 (the aglycone fragment) was chosen as 284 
the only precursor ion. The results are given in Fig. 3.  285 
The observed ions of m/z 253.0501 [C15H9O4]
+
, m/z 243.0657 [C14H11O4]
+
, m/z 197.0603 286 
[C13H9O2]
+
, m/z 169.0650 [C12H9O]
+
, m/z 153.0188 [C7H5O4]
+
 ions are equally typical for 287 
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some flavonoids such as the isoflavone genistein and the flavone apigenin. Nevertheless, this 288 
fact supports the basic assumption that the studied compounds are most probably flavonoid 289 
derivatives. On the other hand, the ion [C13H11O3]
+
 (with the monoisotopic m/z 215.0703), 290 
which is a result of double elimination of CO from the aglycone is specific for isoflavones 291 
like genistein, and atypical for apigenin (Kuhn, Oehme, Romero, Abou-Mansour, & 292 
Tabacchi, 2003; March, Lewars, Stadey, Miao, Zhao, & Metcalfe, 2006; March, Miao, 293 
Metcalfe, Stobiecki, & Marczak, 2004). This ion was common in the spectra of all four 294 
compounds, and was observed with less than 1.5 mDa or 5 ppm error in all cases. This result 295 
provided support that the compounds detected are genistein glycoconjugates.  296 
In order to provide data for additional confirmation, UV spectra of the compounds were also 297 
acquired using the diode array detector (DAD) inserted between the HPLC and TOFMS. The 298 
UV spectra of the compound eluting at 22.73 min and based on MS data was tentatively 299 
identified as genistein-hexoside, well matched those of genistin (tR =21.03 min) and genistein 300 
(tR = 31.33 min). Spectra of these three compounds acquired in ‘Pipacs1’ sample are given in 301 
Fig. 4. In the case of the compound eluting at 21.60 min, contradictory results were obtained. 302 
The UV spectrum of this compound was substantially different from those shown in Fig. 4. 303 
Such differences can be partly explained with the presence of any UV absorbing interferences 304 
in the chromatographic peak. Nonetheless, in contrast with the obtained MS data presented 305 
earlier, the ambiguous UV spectrum observed for this compound did not give support for the 306 
assumption that this compound is a genistein glycoconjugate. With respect to the compound 307 
at 18.33 min, the sensitivity of the UV detector limited our success to acquire UV spectrum 308 
for this compound, which was present only in small amounts in all investigated samples. 309 
 310 
3.3. Quantification of genistein glycoconjugates 311 
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Quantification was carried out using an HPLC-DAD instrument coupled to a tripe quadrupole 312 
ESI-MS/MS instrument. With this coupling quantification could be performed using both MS 313 
and UV data. Since reference substances were available only for genistein aglycone and 314 
genistin, only these two genistein compounds were quantified based on their MS data and 315 
using the standard addition calibration technique. The ESI-MS/MS was used in multiple 316 
reaction monitoring (MRM) mode. Two MRM transitions were selected for each compounds, 317 
namely 433/271 (quantifier) and 271/215 (qualifier) for genistin and 271/153 (quantifier) and 318 
271/215 (qualifier) for genistein aglycone, respectively. Genistein compound eluting at 22.73 319 
min provided pronounced UV signal in the samples where the two other genistein compounds 320 
were also present. Quantitation of this genistein-hexoside was also carried out based on UV 321 
chromatograms. Flavonoids absorb UV light effectively, which is a result of the 322 
chromophores found in the aglycone molecule. The aromatic A-ring of an aglycone, which is 323 
a common chromophore in all flavonoids, results UV absorptions in the 250 nm region of the 324 
absorbance spectrum. It should be noted that substituents without chromophores such as 325 
glycosyl moieties will not significantly change the absorbance spectrum of the given 326 
flavonoid (de Rijke, Out, Niessen, Ariese, Gooijer, & Brinkman, 2006). Therefore, the 327 
characteristic absorption band of genistein aglycone, which has a maximum at 260 nm could 328 
be used for quantitative measurements of the genistein glycoconjugate at 22.73 min. 329 
Concentrations of this genistein-hexoside were calculated using the calibration equation of 330 
genistin. Results are given in mg per 100 gram
 
fresh weight in Table 2.  331 
Out of twelve genotypes, in eight , (‘Oblachiskha’, ‘VN-7’, ‘Érdi bőtermő’, ‘Csengődi’, 332 
‘Cigány404’, ‘Korai pipacs’, ‘VN-4’ and ‘Sárdy SF’) both genistein and genistin were below 333 
the quantification limit of 0.02 mg per 100 g wet weight. However, traces of genistein 334 
compounds were detected in ‘Érdi bőtermő’ and ‘Korai pipacs’. In these samples no UV peak 335 
was obtained for Gen-H (22.73 min). On the contrary, in ‘Pipacs1’, ‘Kántorjánosi’, 336 
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‘Debreceni bőtermő’ and ‘Éva’ genistein compounds was present in considerable amounts 337 
and ‘Pipacs1’ contained genistein compounds at an exceptional high concentration. These 338 
results show that natural variation in the concentration of genistein compounds among sour 339 
cherry cultivars is considerable. It is known to similarly occur in soya (Bhagwat, Haytowitz, 340 
& Holden, 2008; Chan, et al., 2009). As it was shown in a former study on sour cherries, it 341 
can be attributed to the considerable genetic diversity of the sour cherry genotypes native to 342 
the Carpathian Basin, which also display great phenotypic variability. Considerable variation 343 
in terms of fruit weigh, total polyphenol, total acidity, soluble solids, and total anthocyanin 344 
content was reported (Papp, Szilvássy, Abrankó, Szabó, Pfeiffer, Szabó, et al., 2010). The 345 
anthocyanin content of ‘Pipacs1’, ‘Kántorjánosi’, and ‘Debreceni bőtermő’ was measured to 346 
be similarly low, in particular in the range of 10-20 mg cyanidin-glucoside equivalent per 100 347 
g. ‘Pipacs1’ fruit can be characterized with bright red skin and yellow flesh. It is likely that in 348 
these cultivars the anthocyanin biosynthesis is blocked at a currently unidentified step in a 349 
way that down-regulation of the biosynthetic pathway will not result in complete absence of 350 
the end-products. Interestingly, experimental data clarified that key enzymes of polyphenol 351 
biosynthesis (PAL, CHS, DFR, ANS) were expressed even in the yellow fruit flesh of ‘Pipacs 352 
1’ (Papp, et al., 2010). This may result in the over-accumulation of some flavonoid 353 
intermediates including genistein in fruit flesh of ‘Pipacs 1’ and similar cultivars. 354 
 355 
4. Conclusions 356 
When nutritional aspects of genistein are discussed, almost exclusively soy is considered as 357 
the only relevant dietary source. In this study, however, we reported convincing experimental 358 
data obtained by state-of-the-art techniques such as accurate mass tandem mass spectrometry, 359 
that certain sour cherry (Prunus cerasus L.) cultivars contain substantially high amounts of 360 
various genistein compounds. We unambiguously identified genistin and genistein aglycone 361 
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in four commercial sour cherry cultivars ‘Pipacs1’, ‘Kántorjánosi’, ‘Debreceni bőtermő’ and 362 
‘Éva’, which are native to Hungary. The genistein content of ‘Kántorjánosi’, ‘Debreceni 363 
bőtermő’ and ‘Éva’ was in the range of 0.4-0.6 expressed as milligrams of genistein aglycone 364 
equivalents per 100 g of fresh weight. This is overlapping with the values reported in legumes 365 
(e.g. beans, beansprouts). Legumes are considered as potential alternative sources of genistein 366 
to soy products in the Western diet. For instance, in the study of Liggins et al, Mung 367 
beansprouts was reported to be the next richest investigated food following soy-related ones, 368 
with combined genistein and daidzein contents in the range of 0.3-0.6 mg/100g (Liggins, 369 
Bluck, Runswick, Atkinson, Coward, & Bingham, 2000b). In ‘Pipacs1’, a total of 4.4 mg/100 370 
g genistein compounds were measured expressed as milligrams of genistein aglycone 371 
equivalents per 100 g of wet weight. Interestingly, this amount is comparable to some 372 
amounts reported in soy-based foods such as soy cheese or soy drink. In raw mature soybeans 373 
genistein varied widely between 5.6 and 276 mg/100 g, providing an average content of 81 374 
mg/100g (Bhagwat, Haytowitz, & Holden, 2008). Genistein content of ‘Pipacs1’ is 375 
comparable to soy beans with low genistein concentration, produced typically in Europe and 376 
Taiwan.  377 
According to a former study ‘Kántorjánosi’ can be considered as a cultivar with good eating 378 
quality, while ‘Debreceni bőtermő’ is less preferred for fresh consumption due to its lower 379 
soluble solid content. These sour cherry cultivars consumed as fresh products or in the form 380 
of juice may play an important role as complementary genistein sources in the Western diet. 381 
On the contrary, ‘Pipacs 1’ is not suitable for fresh consumption since it is sour and 382 
characteristically astringent due to its low pH and high acidity level as well as high 383 
polyphenolic contents (Papp, et al., 2010). ‘Pipacs 1’ fruits were formerly used for 384 
confectionary purposes and is currently non-utilized. However, due to its outstanding 385 
17 
 
genistein concentration compared to other assayed cultivars, its best future utilisation might 386 
be in functional food products.  387 
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Fig. 1. Overlaid TOFMS extracted ion chromatograms of selected ions used for tentative 
identification of genistein compounds. 
 
Fig. 2. Accurate-mass qTOF mass spectra of m/z 595.1658 at 18.33 min (A), m/z 433.1129 at 
21.03 min (B), 21.60 min (C), and 22.73 min (D). During the qTOFMS experiment the 
quadrupole (q) was working with a 4-Da-wide filtering mass window. 
 
Fig. 3. Accurate-mass qTOF mass spectra of in-source formed fragment ion of m/z 261.0601 
at 18.33 min (A), 21.03 min (B), 21.60 min (C), and 22.73 min (D). Fragmentor voltage of 
210 V was applied in order to encourage in-source fragmentation.  
 
Fig. 4. UV spectra of genistein compounds in ‘Pipacs1’ fruit, obtained from HPLC-DAD 
acquisitions. 
 
